Merck & Co., Inc. (LON:MRK)
London
· Delayed Price · Currency is GBP · Price in GBX 58.50
0.00 (0.00%)
Jun 4, 2025, 12:02 PM BST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2012 - 2020 |
| Pharmaceutical | 57.03B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Growth | 3.94% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Animal Health | 5.95B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Animal Health Growth | 5.47% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Product | 937.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Product Growth | 5.28% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2012 - 2020 |
| United States | 33.32B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 13.73% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe, Middle East and Africa | 13.93B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe, Middle East and Africa Growth | 3.09% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Latin America | 3.46B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Latin America Growth | 7.26% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan | 3.13B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan Growth | -3.07% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Geographic | 2.64B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Geographic Growth | 21.06% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China | 4.42B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | -35.50% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Pacific (other than China and Japan) | 3.02B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Pacific (other than China and Japan) Growth | -2.58% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2012 - 2020 |
| Pharmaceutical Segment Profit | 44.34B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Segment Profit Growth | -1.76% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Animal Health Segment Profit | 2.02B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Animal Health Segment Profit Growth | 14.23% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Segment Profit | -26.19B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Segment Profit Growth | -5.98% |
Log In |
Log In |
Log In |
Log In | Upgrade
|